ASXC (asensus.com) צמיחת רווח נקי למניה השנה

Asensus Surgical, Inc. (ASXC) generates revenue through the sale of consumables and AI licenses for its robots. The shift in earnings per share compared to last year on the GURU.Markets chart confirms this trajectory, where the current level is 0.00. While the company's "digital laparoscopy" technologies are moving medicine toward autonomy, the business is currently undergoing a liquidity shortage and deep restructuring.

Sales of robotic laparoscopy systems and long-term service contracts form the recurring revenue base for Asensus Surgical, Inc. (ASXC). The measured YoY EPS growth trend reflects cost management efficiency and the ability to convert customer technological lock-in into actual earnings per share growth. This indicator allows for an assessment of the business's operational resilience, signaling potential capital stagnation risks to the investor during a downward trend.